Expression of cyclins and cyclin-dependent kinases in smooth muscle tumors of the uterus.
To investigate the cell cycle regulatory mechanisms involved in the growth of smooth muscle tumors, we studied the expression of Ki-67, cyclins E and A, and their catalytic partners, the cyclin-dependent kinases cdk2 and cdc2 by using tissue specimens from benign and malignant smooth muscle tumors. These included 20 cases of usual leiomyoma (UL), 18 of cellular leiomyoma (CL), 8 of bizarre leiomyoma (BL), 8 of uncertain malignant potential tumors (UMP) and 20 of leiomyosarcoma (LMS). The proliferation rate detected by Ki-67 was low in normal myometrium and leiomyomas (UL, CL and BL), but it was markedly increased in LMS. The expression of the cyclins (E and A) and cdks (cdk2 and cdc2) was also low in normal myometrium and leiomyomas. However, the expression of these factors was markedly increased in LMS. In addition, a survival analysis using Log-rank test, revealed that LMSs with positive staining for cyclin A and with diffusely staining for cyclin E were associated with significantly shorter survival. Our results suggest that expression of cyclins and cdks may be involved in the growth control of uterine smooth muscle tumors.
Zhai
Y L
YL
Department of Obstetrics and Gynecology, Shinshu University School of Medicine, Matsumoto, Japan.
Nikaido
T
T
Shiozawa
T
T
Orii
A
A
Fujii
S
S
D000328:Adult; D000368:Aged; D016203:CDC2 Protein Kinase / Q000032:analysis*; D042846:CDC2-CDC28 Kinases; D019925:Cyclin A / Q000032:analysis*; D019927:Cyclin E / Q000032:analysis*; D051357:Cyclin-Dependent Kinase 2; D018844:Cyclin-Dependent Kinases / Q000032:analysis*; D005260:Female; D006801:Humans; D015151:Immunoblotting; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000032:analysis; D007889:Leiomyoma / Q000737:chemistry* / Q000401:mortality; D007890:Leiomyosarcoma / Q000737:chemistry* / Q000401:mortality; D008875:Middle Aged; D017346:Protein Serine-Threonine Kinases / Q000032:analysis*; D014594:Uterine Neoplasms / Q000737:chemistry* / Q000401:mortality
D019925:Cyclin A; D019927:Cyclin E; D019394:Ki-67 Antigen; D017346:Protein Serine-Threonine Kinases; D016203:CDC2 Protein Kinase; D042846:CDC2-CDC28 Kinases; C495894:CDK2 protein, human; D051357:Cyclin-Dependent Kinase 2; D018844:Cyclin-Dependent Kinases